Northwest Biotherapeutics increases authorized common shares from 1.2B to 1.7B

NORTHWEST BIOTHERAPEUTICS INC

Filed Certificate of Amendment with Delaware Secretary of State on January 9, 2023.
Authorized shares of common stock increased by 500 million to 1.7 billion; par value remains $0.001.
No concurrent offering or use of proceeds disclosed in the filing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NORTHWEST BIOTHERAPEUTICS INC: Increased authorized shares of common stock from 1,200,000,000 to 1,700,000,000 (effective 2023-01-09).

Change: charter amendment
Effective: 2023-01-09

Exact text from the filing

On January 9, 2023, the Company filed a Certificate of Amendment of its Seventh Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of the State of Delaware, which effected an increase in the Company’s authorized shares of common stock, from 1,200,000,000 to 1,700,000,000, par value $0.001 per share.

View on SEC.gov

Browse all governance changes →

NORTHWEST BIOTHERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001104659-23-003846

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.